VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 199 filers reported holding VIKING THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $969,078 | -20.8% | 19,343 | +29.7% | 0.04% | -13.7% |
| Q1 2024 | $1,223,181 | +357.5% | 14,917 | +3.8% | 0.05% | +264.3% |
| Q4 2023 | $267,348 | +107.5% | 14,366 | +6.8% | 0.01% | +75.0% |
| Q3 2023 | $128,841 | -38.1% | 13,449 | 0.0% | 0.01% | -11.1% |
| Q2 2023 | $208,191 | – | 13,449 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |